The U.N. celebrates a regulatory debacle.

Area of Science:

• Biotechnology Regulation
• International Environmental Law
• Genetic Engineering Policy

Background:

• Negotiation of the Cartagena Protocol on Biosafety under the Convention on Biological Diversity in the early 2000s.
• The protocol regulates international movement of living modified organisms (LMOs) developed using precise genetic modification techniques.
• The protocol's foundation is the precautionary principle, requiring absolute proof of safety before use.

Purpose of the Study:

• To critically evaluate the effectiveness and scientific soundness of the UN's biosafety protocol.
• To analyze the impact of the precautionary principle on the development and approval of new biotechnologies.
• To examine the regulatory framework's role in hindering innovation and product development.

Main Methods:

• Analysis of the biosafety protocol's regulatory framework and its implementation.
• Assessment of the application of the precautionary principle in LMO regulation.
• Review of the protocol's impact on the development of genetically modified organisms.

Main Results:

• The biosafety protocol, based on the precautionary principle, has created an amorphous and scientifically unsound regulatory process.
• The protocol encourages risk-averse, incompetent, or corrupt regulatory practices, leading to delays and denials of approvals.
• The protocol acts as a self-defeating impediment to the development and adoption of beneficial new biotechnologies.

Conclusions:

• The UN's biosafety protocol has failed to establish a predictable and scientifically sound framework for managing risks associated with LMOs.
• The protocol's reliance on the precautionary principle stifles innovation and hinders the progress of biotechnology.
• There is a need for a revised, science-based approach to biosafety regulation that balances risk management with technological advancement.